Back

Hippo/YAP1 Signaling Regulates the Oligodendrocyte-Astrocyte Fate Switch and Ependymal Gene Expression in Adult Spinal Cord Stem Cells

Joppe, S.; Chevreau, T.; Abou-chaaya, J.; Garcia, L.; Hansberg-pastor, V.; Hideg, S.; Ripoll, C.; Ghazale, H.; Nouhaud, A.; Lalli, E.; Ruggiero, C.; Zhang, L.; Chen, M.; Lugand, S.; Urbach, S.; El-koulali, K.; Seveno, M.; Poulen, G.; Vachiery-Lahaye, F.; Bauchet, L.; Hugnot, J.-P.

2025-10-03 cell biology
10.1101/2025.10.01.677488 bioRxiv
Show abstract

The adult mammalian spinal cord harbors ependymal cells that retain neural stem-cell properties. Although they possess a latent capacity to generate oligodendrocytes, these cells predominantly differentiate into astrocytes after injury. The molecular cues that govern their lineage commitment toward astrocytic versus oligodendroglial fates remain poorly defined. In this study, we addressed this gap in vitro by investigating the emergence of PDGFRA oligodendrocyte precursor cells (OPCs) in neurosphere cultures derived from adult spinal cord stem cells. We first observed that neurosphere cells exhibited a hybrid identity, co-expressing transcription factors of both astrocytic (NFIA, SOX9) and oligodendrocytic (OLIG1/2, SOX4, NKX2.2, TCF4) lineages. Upon differentiation, oligodendrocytic transcription factors were selectively maintained in OPCs but reduced in other cells. Using PdgfraH2B-GFP mice, we then isolated newly formed PDGFRA OPCs from neurospheres and performed multi-omic profiling. OPC formation was associated with the upregulation of chromatin remodelers and the downregulation of stem-cell markers such as EGFR, HES1, and TNC. Strikingly, OPC specification coincided with reduced expression of YAP1 and its partner TEAD1, key effectors of the Hippo pathway. Functional analyses revealed that YAP1 loss enhanced oligodendrocytic differentiation while reducing astrocytic and ependymal/cilia-associated gene expression. Conversely, constitutive YAP1 activation blocked differentiation into both lineages and promoted an ependymal-like transcriptional program, including upregulation of the ependymal marker CD24a and cilia-related proteins such as CROCC (Rootletin). Collectively, these findings uncover previously unrecognized roles for YAP1 in adult spinal cord stem-cell fate decisions and provide a molecular framework for leveraging these cells in regenerative strategies targeting spinal cord repair.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Cell Stem Cell
57 papers in training set
Top 0.1%
33.6%
2
Cell Reports
1338 papers in training set
Top 0.6%
15.0%
3
Nature Communications
4913 papers in training set
Top 24%
7.3%
50% of probability mass above
4
Developmental Cell
168 papers in training set
Top 4%
4.9%
5
Stem Cell Reports
118 papers in training set
Top 0.1%
4.4%
6
Stem Cells
28 papers in training set
Top 0.1%
4.0%
7
eLife
5422 papers in training set
Top 32%
2.6%
8
Science Advances
1098 papers in training set
Top 14%
1.9%
9
JCI Insight
241 papers in training set
Top 3%
1.7%
10
EMBO reports
136 papers in training set
Top 4%
1.4%
11
Molecular Cell
308 papers in training set
Top 9%
1.0%
12
iScience
1063 papers in training set
Top 24%
1.0%
13
Journal of Cell Biology
333 papers in training set
Top 4%
0.9%
14
PLOS Biology
408 papers in training set
Top 16%
0.9%
15
Scientific Reports
3102 papers in training set
Top 70%
0.9%
16
Advanced Science
249 papers in training set
Top 17%
0.8%
17
Stem Cell Research & Therapy
30 papers in training set
Top 0.7%
0.8%
18
Nature Cell Biology
99 papers in training set
Top 4%
0.8%
19
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 44%
0.8%
20
npj Regenerative Medicine
21 papers in training set
Top 0.3%
0.8%
21
Genes & Development
90 papers in training set
Top 1%
0.7%
22
Cell Death & Disease
126 papers in training set
Top 3%
0.7%
23
Cell Reports Methods
141 papers in training set
Top 7%
0.5%
24
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 12%
0.5%
25
Cell Reports Medicine
140 papers in training set
Top 10%
0.5%